Roxas, Glore Jean V.
HRN: 12-96-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2025
CEFUROXIME 1.5GM (VIAL)
03/17/2025
03/18/2025
IV
1.5
Q8hr X 3 Doses
Sp NSVD With RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes